NOTE 10: - SAFE

During the period from November 2025 through June 2026, Kokomodo entered into a series of SAFE agreements with various investors for an aggregate amount of $714. Pursuant to the terms of the SAFE agreements, in the event of an Equity Financing, as defined in the applicable SAFE agreements as a capital raising transaction or series of transactions, pursuant to which (i) Kokomodo issues and sells a new series of preferred shares of Kokomodo at a fixed pre-money valuation; and (ii) at least 25% of the amount of the capital raised is not attributed to the SAFE Investors (as defined in the SAFE agreements), the investment will be automatically converted into the number of most senior preferred shares of Kokomodo, equal to the purchase amount divided by either: (1) the price per share equal to a Valuation Cap (as defined in the SAFE agreements) divided by Kokomodo Capitalization (as defined in the SAFE agreements), or (2) the price per preferred share sold in the Equity Financing discounted by 20%.

As of June 30, 2026, the fair values of the SAFE agreements were estimated at $794. The fair value of the SAFE agreements were estimated using a probability weighted scenario analysis using the Black-Scholes option pricing model, using an expected volatility of 64.69%, a risk-free rate of 4.19%, and a contractual term of 5 years. The SAFE was classified as a long-term liability, accounted at fair value, with remeasurement at each reporting period (see note 2u). Changes in the estimated fair value of the SAFE agreements amounted to $80 and are recognized in “Other Financial income (expenses), net” in the consolidated statements of operations (see also note 14). The SAFE instrument, is classified within Level 3 of the fair value hierarchy (see note 2u).